Seller record · altrx.com

altRx

Recorded September 2026 · Standard v1.1

Fails 2 of 8 criteria. S5, analytical documentation: Eight pages were read, covering home, about, contact, terms, privacy and the frequently asked questions, and none publishes a certificate of analysis, a lot number or a testing claim. 1 more criterion also fails; see the table below.

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A telehealth membership selling compounded semaglutide and tirzepatide. It names four filling pharmacies with street addresses, and an FDA warning letter names the operating entity.

Operating entity Trinity Healthcare Supply LLC

Dispositions

Code	Criterion	Disposition	Where it was read
S1	Prescriber requirement	PASS	altrx.com/about
S2	Prescription gating	PASS	altrx.com
S3	Pharmacy identification	PASS	altrx.com/about
S4	Compounding disclosure	PASS	altrx.com/about
S5	Analytical documentation	FAIL	altrx.com
S6	Business address	FAIL	altrx.com/privacy
S7	Price disclosure	PASS	altrx.com
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

What was read, where, and on what date, for each disposition in the table above.

S1PASSMedical services, including clinical evaluation and prescribing, are stated to be provided by OpenLoop Healthcare Partners, PC and its affiliated professional medical practices.Source: altrx.com/about.

S2PASSThe order path was walked from the homepage and stopped at an eligibility intake headed check your eligibility for GLP-1 treatment, before any product or payment screen.Source: altrx.com.

S3PASSFour pharmacies named with street addresses and telephone numbers: RedRock Pharmacy in St. George, Health Warehouse in Florence, Precision Medicine in Bellmore, and Triad Rx in Daphne.Source: altrx.com/about.

S4PASSA reader-visible page states the medications are compounded and are not FDA approved or evaluated by the FDA.Source: altrx.com/about.

S5FAILEight pages were read, covering home, about, contact, terms, privacy and the frequently asked questions, and none publishes a certificate of analysis, a lot number or a testing claim.Source: altrx.com.

S6FAILFooter, contact, terms and privacy were read, and none prints a street address for the operating business. The only postal address printed on any of them belongs to Openloop, Inc. in Alpharetta, Georgia, which is the clinical platform rather than the seller.Source: altrx.com/privacy.

S7PASSPrices printed on the homepage: 89 dollars monthly for GLP-1 and 149 dollars monthly for GLP-1 plus GIP, described as the same price every month.Source: altrx.com.

S8PASSFDA warning letter 728236, June 2026, names Trinity HealthCare Supply, LLC dba altRx and alleges misbranding; no FDA action has halted the business, and the seller still trades.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide.

Enforcement documents on file: 1 warning letter

FDA warning letter 728236, issued June 2026, to Trinity HealthCare Supply, LLC dba altRxA pictured label identifies altRx as the compounder of semaglutide and tirzepatide products when it is not, and claims that the products are clinically proven represent them as FDA-approved when they are not.

A warning letter alleges violations and requests a response. It does not halt a business, and it does not remove a seller from this ledger. Every letter recorded here.

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.